Inventor · disambiguated record
José L. Boyer
Also filed as: BOYER JOSE L · BOYER JOSÉ L
18 granted patents·6 pending applications·279 citations·filing 2000–2022
94Inventor score
Files withINSPIRE PHARMACEUTICALS INC12UNIV NORTH CAROLINA3NICOX OPHTHALMICS INC2BOYER JOSE L1DOUGLASS III JAMES G1
Top patents by PatentIndex Score
24 records- 0194US7618949B2Drug-eluting stents coated with P2Y12 receptor antagonist compoundINSPIRE PHARMACEUTICALS INC·Filed 2008·Granted Nov 17, 2009·13 cites·8 claims
- 0294US7018985B1Composition and method for inhibiting platelet aggregationUNIV NORTH CAROLINA·Filed 2000·Granted Mar 28, 2006·78 cites·38 claims
- 0393US7335648B2Non-nucleotide composition and method for inhibiting platelet aggregationINSPIRE PHARMACEUTICALS INC·Filed 2005·Granted Feb 26, 2008·15 cites·23 claims
- 0492US7851456B2P2Y6 receptor agonists for treating lung diseasesINSPIRE PHARMACEUTICALS INC·Filed 2006·Granted Dec 14, 2010·17 cites·14 claims
- 0592US6897201B2Compositions and methods for the treatment of glaucoma or ocular hypertensionINSPIRE PHARMACEUTICALS INC·Filed 2002·Granted May 24, 2005·52 cites·11 claims
- 0689US7452870B2Drug-eluting stents coated with P2Y12 receptor antagonist compoundINSPIRE PHARMACEUTICALS INC·Filed 2005·Granted Nov 18, 2008·5 cites·21 claims
- 0788US7749981B2Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compoundINSPIRE PHARMACEUTICALS INC·Filed 2005·Granted Jul 6, 2010·5 cites·19 claims
- 0887US8158776B2P2Y6 receptor agonists for treating lung diseasesBOYER JOSE L·Filed 2010·Granted Apr 17, 2012·11 cites·5 claims
- 0987US7943760B2Non-nucleotide composition for inhibiting platelet aggregationINSPIRE PHARMACEUTICALS INC·Filed 2009·Granted May 17, 2011·4 cites·8 claims
- 1086US7592445B2Non-nucleotide composition and method for inhibiting platelet aggregationINSPIRE PHARMACEUTICALS INC·Filed 2008·Granted Sep 22, 2009·3 cites·12 claims
- 1184US8349806B2Method of treating blepharitisINSPIRE PHARMACEUTICALS INC·Filed 2009·Granted Jan 8, 2013·15 cites·21 claims
- 1284US7368438B2Non-nucleotide compositions and method for inhibiting platelet aggregationINSPIRE PHARMACEUTICALS INC·Filed 2004·Granted May 6, 2008·20 cites·14 claims
- 1383US7435724B2Degradation-resistant mononucleoside phosphate compoundsINSPIRE PHARMACEUTICAL INC·Filed 2005·Granted Oct 14, 2008·10 cites·21 claims
- 1483US7132408B2Composition and method for inhibiting platelet aggregationUNIV NORTH CAROLINA·Filed 2004·Granted Nov 7, 2006·20 cites·27 claims
- 1577US7101860B2Composition and method for inhibiting platelet aggregationUNIV NORTH CAROLINA·Filed 2001·Granted Sep 5, 2006·10 cites·17 claims
- 1675US11406596B2Process for the preparation of sterile ophthalmic aqueous fluticasone propionate form a nanocrystals suspensionsNICOX OPHTHALMICS INC·Filed 2020·Granted Aug 9, 2022·1 cites·25 claims
- 1765US7612047B2Degradation-resistant mononucleoside phosphate compoundsINSPIRE PHARMACEUTICALS INC·Filed 2008·Granted Nov 3, 2009·0 cites·6 claims
- 1861US2010008968A1Method for treating cardiovascular diseases using rho kinase inhibitor compoundsLAMPE JOHN W·Filed 2009·Application pending·0 cites
- 1960US2010160250A1Method for treating inflammatory conditionsDOUGLASS III JAMES G·Filed 2009·Application pending·0 cites
- 2060US2022323352A1Process for the preparation of sterile ophthalmic aqueous fluticasone propionate form a nanocrystals suspensionsNICOX OPHTHALMICS INC·Filed 2022·Application pending·0 cites
- 2159US8168597B2Method for treating cystic fibrosisKELLERMAN DONALD J·Filed 2009·Granted May 1, 2012·0 cites·15 claims
- 2257US2013172324A1Method for treating cardiovascular diseases using rho kinase inhibitor compoundsINSPIRE PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2353US2009098064A1Method of treating pulmonary edema or pulmonary inflammationNAVRATIL TOMAS·Filed 2007·Application pending·0 cites
- 2442US2005130931A1Compositions for the treatment of glaucoma or ocular hypertensionFiled 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when José L. Boyer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →